Superstring Capital

Founded 2019

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 4
Average round size
info
The average size of a deal this fund participated in
$93M
Portfolio companies 4
Rounds per year 2.00
Lead investments 0
Key employees Soon
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Medical
  • Biopharma
  • Pharmaceutical
  • Clinical Trials

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Superstring Capital:
Typical Co-investors
Superstring Capital is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Superstring Capital:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United States, New York
Funds with similar focus located in United States, New York:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Power Generations, Inc. United States, Pompano Beach
Marlin Equity Partners United States, Hermosa Beach
Montlake Capital United States, Seattle
Incapital United States, Chicago
Redfig -
3D Systems United States, Rock Hill
Gamma3 Brazil, Curitiba
Oman Investment Fund Oman, Masqat
L-EigenkapitalAgentur Germany, Karlsruhe
Transmedia Ventures United States, San Francisco
Verbena Communications -
Caribou Asset Management -
Shoei Chemical -
Jinfu Ziben China, Beijing
Ibtikar Fund Palestinian Territory, West Bank
Tricle Japan, Tokyo
Katana Fund -
L-EigenkapitalAgentur -
Cronus Bike China, Panyu District

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

dMed

Biopharma
Medical
Pharmaceutical
1
$50M10 Jul 2021 China, Shanghai

Clinipace

Biotechnology
Clinical Trials
Medical
n/a
$50M08 Jul 2021 United States, " United States"}

Biopharma
Biotechnology
Health Care
Pharmaceutical
1
$105M13 May 2021 China, Shanghai

AffaMed Therapeutics

Biotechnology
1
$170M30 Mar 2021 United States, " United States"}
News
ReCode Therapeutics Raises Oversubscribed Series B Financing Round of $80 Million

– ReCode Therapeutics announced the closing of an $80m Series B financing round co-led by Pfizer Ventures and EcoR1 Capital.
– The round was led by Pfizer Ventures and EcoR1 Capital.
– New investors include Sanofi Ventures, funds managed by Tekla Capital Management, Superstring Capital and NS Investment.
– Existing investors who participated included OrbiMed, Vida Ventures, MPM Capital, Colt Ventures, Hunt Technology Ventures, and Osage University Partners.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Superstring Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: